E Reed

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

Meenakshi Dabholkar, Justine Vionnet, Jin‐Tai Yu et al. · Journal of Clinical Investigation · 1994 · 446 citations · Full text

Ercc1 Mrna, Oncogenic Agent, Medicine +15

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins et al. · PubMed · 1996 · 361 citations

Oncology, Medicine, Mevalonate Pathway +11

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

W D Figg, William Dahut, Paul H. Duray et al. · PubMed · 2001 · 304 citations

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.

R. J. Parker, Alan Eastman, E Reed · Journal of Clinical Investigation · 1991 · 299 citations · Full text

Cell Lines A2780, Cisplatin-dna Lesions, Medicine +14

Antitumor effect of β-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death

G. Wang, X. Li, Furong Huang et al. · Cellular and Molecular Life Sciences · 2005 · 240 citations · Full text

Medicine, Apoptotic Cell Death, Pharmacology +11